At its Annual General Meeting (AGM) on 22 March 2012, the Supervisory Board of Carlsberg will recommend that the AGM appoints Ms. Donna Cordner, Ms. Elisabeth Fleuriot and Søren-Peter Fuchs Olesen to join the Board.
Commenting on this move, Povl Krogsgaard-Larsen, Chairman of the Board, said:
"Last year, we agreed that we needed to review the composition of our Board. While there are some pre-determined competencies that we require of our members, we also recognise the benefits of a diverse board in respect of experience, style, culture, international experience and gender.”
The Supervisory Board has set itself a range of new objectives which include:
• By no later than 2015, at least 40% of the Supervisory Board members elected by the General Meeting should be women;
• 50% or more of the Supervisory Board members elected by the General Meeting should have significant international experience from management in, and of large corporations or institutions; and
• that the Carlsberg Group will increase the number of women in senior management positions and will prepare and implement specific action plans to achieve this.
"At the forthcoming Annual General Meeting, we will be taking the first steps towards fulfilling some of these targets. These new appointments will provide us with even more international and FMCG experience, as well as further reinforcing our commitment towards corporate social responsibility", adds Povl Krogsgaard-Larsen.
Søren-Peter Fuchs Olesen is nominated as the successor for Povl Krogsgaard-Larsen as member of the Board. The two other positions are new. By extending the Supervisory Board with two new members, the Board will after the AGM's approval have five members with close links to the Carlsberg Foundation, five professional business members and four members elected by the employees.
Further background on proposed new Supervisory Board members:
Ms. Donna Cordner. Born 1956. Non-executive Director of Millicom International Cellular SA since May 2004 and currently member of the Audit Committee and CSR Committee. Ms. Cordner was formerly Managing Director and Global Head of Telecommunications and Media Structured Finance at Citigroup. She has also held senior management positions at Société Générale and ABN Amro Bank N.V. in the U.S. and Europe, including as Head of ABN's Global Telecommunications Client practice. Until July 2005, Ms. Cordner was the Chief Executive Officer of HOFKAM Limited, which is the largest rural microfinance company in Uganda, and she continues to advise HOFKAM as a consultant. She was named Executive Vice President of Corporate Finance and Treasury for Tele2AB effective March 2007 and was Market Area Director and Chief Executive Officer for Russia between March 2008 and July 2009. Ms. Cordner has extensive international management experience, also from growth markets. She has substantial experience with financial management and financial reporting processes, stakeholder and investor relations management and with the assessment and mitigation of business risks. She has also worked extensively with performance management and CSR and sustainable development.
Ms. Elisabeth Fleuriot. Born 1956. Senior Vice President Emerging Markets and Vice President Kellogg Company. Ms Fleuriot has acquired substantial international branded consumer goods and management experience through her career in management positions in the Kellogg Company (since 2001) and before that in Yoplait (Soodiaal Group) and the Danone Group. Ms. Fleuriot has extensive experience from sales and marketing management, product innovation, strategic planning and has wide international experience from developed and emerging markets. She has worked on business development, acquisitions and partnerships and has a wide understanding of the assessment and mitigation of business risks.
Søren-Peter Fuchs Olesen. Born 1955. Professor, D.Med. Member of the Board of Directors of the Carlsberg Foundation and the Supervisory Board of the Carlsberg Laboratory. Director of the Danish National Research Foundation Centre for Cardiac Arrhythmia at University of Copenhagen and Rigshospitalet from 2005. Mr Olesen has been involved in starting up and developing several pharma- and device-companies as co-founder, CEO, scientific director and board member. He has substantial experience in managing knowledge organisations, turning basic science into new products, innovation and planning. He is chairman of the evaluation committees for visiting scientists in the Danish National Bank and The Nordea Foundation, respectively. Mr Olesen has worked extensively with funding and investor relations and has wide experience with CSR
Investor Relations:Iben Steiness +45 3327 1232
Ben Morton, Int. Media: +45 2278 1417
Jens Bekke; Danish Media: +45 3327 1412